Publication | Closed Access
Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells
29
Citations
55
References
2018
Year
Breast OncologyMedicineInduced InflammationBreast Cancer CellsImmunologyBreast CancerAnti-cancer AgentCell BiologyCancer TreatmentOncologyRadiation OncologyTumor MicroenvironmentCancer Growth
| Year | Citations | |
|---|---|---|
Page 1
Page 1